Lipoprotein metabolism and lipid management in chronic kidney disease.
about
Effects of fish oil on serum lipid profile in dialysis patients: a systematic review and meta-analysis of randomized controlled trialsThe association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohortUnfractionated heparin for hemodialysis: still the best option.Pharmacotherapy of end-stage renal disease.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represSerum amyloid A and clusterin as potential predictive biomarkers for severe hand, foot and mouth disease by 2D-DIGE proteomics analysis.Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography.Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level.Dyslipidemia associated with chronic kidney diseaseQuantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal TransplantationEffect of colestilan on serum phosphorus in dialysis patients: A meta-analysis of the literature.Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to DialysisSerum amyloid A in uremic HDL promotes inflammationRisk factors of cardiovascular disease among children with chronic kidney disease in Gaza strip.Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control studySevelamer for hyperphosphataemia in kidney failure: controversy and perspective.Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population.Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cellsLow body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.A prospective controlled study of kidney donors: baseline and 6-month follow-up.Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin.Inappropriately repeated lipid tests in a tertiary hospital in Greece: the magnitude and cost of the phenomenon.Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6.Dyslipidemia in patients with chronic and end-stage kidney disease.Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysisDyslipidemia in patients with chronic kidney disease: etiology and management.Unusual Dyslipidemia in Patients with Chronic Kidney Diseases.Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.Dyslipidemia in children with CKD: should we treat with statins?Statins in the management of dyslipidemia associated with chronic kidney disease.Clinical assessment and management of dyslipidemia in patients with chronic kidney disease.Lipoprotein(a): resurrected by genetics.Is lipid management effective for all stages of CKD?.Lipoprotein metabolism and CKD: overview.Causes and consequences of lipoprotein(a) abnormalities in kidney disease.In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy.
P2860
Q27027802-D9E10DEF-EC20-471F-A210-E1CF8590C85FQ28742141-78636F67-ED92-479D-97D6-ED91912F69A5Q33392592-85F33BE7-2C3A-44B0-8D62-911994C98D96Q33531889-666EDAB6-DF82-405B-BA3C-FF5AE716E2DAQ34046881-C63EEFEA-6F3D-4440-BC91-447B2BE4EBE6Q34277441-233A5AD8-8E47-4DC3-9995-531D85660C7FQ34508691-6DB7B07A-6B70-4255-B1E6-F2F0FA0F57E6Q34572435-BFEF074C-772C-4898-8B65-74A6522E04F8Q35007909-B78491B7-45FB-4FD1-8BC9-C57CF9CE236CQ35020237-9407B2A7-59A7-44A4-8C64-8D8EC5589744Q35051225-2A6B587D-85FB-4C9E-8D26-E830DF592610Q35675305-6B3F626D-B60E-4A30-A233-9139A72606B4Q35745578-D38583E6-9D56-48A2-8065-83E1B05691FBQ35748583-49207FE6-38D2-43B5-98F8-7C2DA39895ADQ35917487-543C326E-4BF4-4CA0-A161-53D8A44A8CFDQ35966672-F970AB7B-E4A0-417D-A3DC-276DAF855966Q36197717-40FA53ED-3899-430B-B255-92BA1972DF52Q36243259-EFA155A9-E8CE-4E8F-A6BD-87BE8F598397Q36443804-65F93CFA-DE35-45BB-AB93-43BE758D11F7Q36735361-FD42BBDB-5779-4288-BD50-D4FE51EB2196Q36996652-7C83CB01-2EDF-4818-9F4E-A09463F50FCAQ37029683-6B751DCC-9646-488F-B71F-EC387D1471D7Q37048746-16C300F5-E150-46F6-80C1-03EB6519BBBDQ37065629-1540AB99-14EC-41B6-B289-85C6DA3B63BAQ37083188-AE2A9C4D-3321-498A-A698-29F9B25FA322Q37314809-2650830D-D591-430C-8E1D-680AD85AAEF7Q37378495-FC5C8ABE-8938-4D48-8031-AE47F9507C2CQ37447007-F71DAC63-5530-4FB8-AD8B-13B3C45AC60BQ37542828-E90490BA-88FD-42AD-998B-AB5DC4298BA9Q37638707-9783D708-CBA4-4640-B04C-371465B0D438Q37663597-B7E975F9-251C-48F3-A50E-701D602F3A7EQ37775007-3484B813-62FA-46AF-8B0A-5EA4C6112361Q37864579-169378DA-AD7A-4E3F-9E92-1F88824507FCQ37986355-7E067B0A-72C8-4E23-B46F-CA1CA9C884B5Q38020764-48EDA877-AD5C-4E90-B4A3-C821E3F94E20Q38045424-0D357B91-73C4-4C78-A842-A16879901872Q38076216-A6B4E251-66FF-4232-B243-1E3A5257E312Q38139864-8B6EE816-2E08-4A99-9401-E8A9B46931BFQ38152960-85D24F14-D4D0-4C71-A947-A2690015D87DQ38244010-31FCDC13-5069-4C88-AC1B-BCDAF67852E3
P2860
Lipoprotein metabolism and lipid management in chronic kidney disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Lipoprotein metabolism and lipid management in chronic kidney disease.
@ast
Lipoprotein metabolism and lipid management in chronic kidney disease.
@en
type
label
Lipoprotein metabolism and lipid management in chronic kidney disease.
@ast
Lipoprotein metabolism and lipid management in chronic kidney disease.
@en
prefLabel
Lipoprotein metabolism and lipid management in chronic kidney disease.
@ast
Lipoprotein metabolism and lipid management in chronic kidney disease.
@en
P356
P1476
Lipoprotein metabolism and lipid management in chronic kidney disease
@en
P2093
Alfred K Cheung
Srinivasan Beddhu
P304
P356
10.1681/ASN.2006091006
P577
2007-03-14T00:00:00Z